|
Market Closed -
Canadian Securities Exchange
09:43:48 23/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.005000 CAD | 0.00% |
|
0.00% | -66.67% |
| Market Cap | 7L 5L 4L 4L 4L 4.55Cr 7L 47.63L 18.86L 2.39Cr 18.01L 17.62L 7.52Cr | P/E 2024 |
-1.31x | P/E 2025 | -4.23x |
|---|---|---|---|---|---|
| Enterprise Value | 21.72L 15.53L 13.87L 12.81L 11.61L 15Cr 22.08L 1.54Cr 61.03L 7.72Cr 58.28L 57.04L 24Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
77.22% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| PHRX | Delayed | |
OTC Markets
| LMLLF | Delayed | |
|
Deutsche Boerse AG
| G11 | Delayed | |
|
Boerse Muenchen
| G11 | Real-time |
| 3 months | -50.00% | ||
| 6 months | -50.00% | ||
| Current year | -66.67% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.02 |
| 1 year | 0 | | 0.02 |
| 3 years | 0 | | 0.08 |
| 5 years | 0 | | 0.46 |
| 10 years | 0 | | 4.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kyle Appleby
DFI | Director of Finance/CFO | 50 | 20/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul McClory
BRD | Director/Board Member | 82 | 20/12/2016 |
David Kideckel
CHM | Chairman | - | 27/02/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/10/25 | Other | Chairman | 13,80,000 | 1.2929% | ||
| 03/05/24 | Other | Director | 0 | 0% | ||
| 03/05/24 | Option | Director | 5,00,000 | 0.5718% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -50.00% | -83.33% | 5L | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,13500Cr | |
| -1.42% | +3.23% | +38.56% | +74.44% | 64TCr | |
| +0.16% | +0.08% | +25.29% | +95.23% | 50TCr | |
| -0.31% | +3.09% | +44.14% | +64.80% | 38TCr | |
| -1.34% | -0.47% | +66.04% | +41.00% | 36TCr | |
| -0.68% | +2.65% | +22.98% | +50.39% | 29TCr | |
| -1.20% | +3.04% | +2.33% | +22.86% | 27TCr | |
| -1.79% | +1.57% | +50.56% | +59.08% | 24TCr | |
| -0.73% | -0.10% | +29.02% | +99.67% | 19TCr | |
| Average | -0.98% | +1.95% | +28.32% | +53.91% | 40.04TCr | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +79.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -8L -6L -5L -5L -4L -5.38Cr -8L -56.3L -22.29L -2.82Cr -21.29L -20.83L -8.89Cr | -4L -3L -2L -2L -2L -2.6Cr -4L -27.21L -10.77L -1.36Cr -10.29L -10.07L -4.3Cr |
| Net Debt | 12.74L 9L 8L 8L 7L 8.65Cr 12.95L 90.42L 35.8L 4.53Cr 34.18L 33.46L 14Cr | 15.01L 10.73L 10L 9L 8L 10Cr 15.26L 1.07Cr 42.17L 5.34Cr 40.27L 39.41L 17Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | CA$0.005000 | 0.00% | 7,000 |
| 22/26/22 | CA$0.005000 | 0.00% | 5,000 |
| 21/26/21 | CA$0.005000 | 0.00% | 20,682 |
| 20/26/20 | CA$0.005000 | 0.00% | 1,035 |
| 19/26/19 | CA$0.005000 | 0.00% | 3,464 |
- Stock Market
- Stocks
- PHRX Stock
Select your edition
All financial news and data tailored to specific country editions
